Fundz
Following Integra LifeSciences?

Get the free weekly executive digest

The latest leadership moves, like Integra LifeSciences’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Integra Life Sciences Appoints Stuart Essig As Chief Executive Officer

PUBLIC · IARTMay 06, 2026about 2 months ago

Position

Chief Commercial Officer

Company

Integra LifeSciences

Michael McBreen
PrincetonBiotechnologyHealth CareMedicalMedical Device

Description

Stuart Essig has returned as CEO of Integra LifeSciences, replacing Mojdeh Poul. Michael McBreen has also been appointed as Chief Commercial Officer in conjunction with the leadership changes.

Company Information

Company

Integra LifeSciences

Location

Princeton, New Jersey, United States

About

Integra LifeSciences is a world leader in medical technology with headquarters in Princeton, New Jersey. We are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership medical technology brands. Our company has offices, manufacturing and research facilities in Asia, Australia, Europe, Middle East, and the Americas.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Integra LifeSciences's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.